Trial is designed to assess the Clotild sensor's capability to detect various characteristics of blood vessel blockages in peripheral artery disease patients.
The partnership will benefit the CORCINCH-HF pivotal clinical trial, which is evaluating the safety & efficacy of the AccuCinch Ventricular Restoration System.
The trial demonstrated a significant reduction from baseline in monthly migraine days in patients treated with Nerivio, compared with a placebo device.
Study will evaluate efficacy of the Isolator Synergy Clamp in conjunction with endocardial catheter ablation for treating Inappropriate Sinus Tachycardia.